脳イメージングデバイスの市場規模、シェア、動向分析レポート：製品別、用途別、最終用途別、地域別、セグメント別予測、2024年～2030年

脳イメージングデバイス市場の成長と動向：

脳イメージングデバイスの世界市場規模は、2024年から2030年にかけてCAGR 8.14%で成長し、2030年には90億4,000万米ドルに達すると予測されます。

市場成長を促進する主な要因としては、技術の進歩、研究開発活動の増加、脳や神経疾患の有病率の増加などが挙げられます。例えば、国際がん研究機関は、2022年に全世界で約32万1,731例の脳・中枢神経系がんが発生したと報告しています。このタイプのがんは、他のすべての種類のがんの中で19位にランクされると指摘されています。

技術的進歩は、市場成長に寄与する主な要因の1つであると予想されます。これらの進歩は、画像分解能の向上、データ処理能力の改善、新規画像モダリティの開発など、さまざまなイノベーションを包含しています。こうした進歩は、脳画像の精度と効率を高めるだけでなく、神経科学、神経学、精神医学、脳神経外科などさまざまな分野への応用を拡大します。例えば、フィリップスは2024年2月、磁気共鳴画像法（MRI）ソフトウェアソリューションの専門企業であるシンセティックMRと提携し、多発性硬化症（MS）、外傷性脳損傷（TBI）、認知症などの脳障害の診断や治療効果の評価に客観的な意思決定支援を提供する注目すべき進歩であるSmart Quant Neuro 3Dを発表しました。Smart Quant Neuro 3D技術は、様々な脳組織の自動測定を提供し、脳疾患の意思決定を支援します、

病気の進行をモニターし、治療結果を評価します。

さらに、神経疾患の有病率の上昇と人口の高齢化は、高度な脳画像技術に対する需要の増加に寄与しています。継続的な研究開発が技術革新と市場拡大の原動力となっています。さらに、市場参入企業によるさまざまな取り組みが、市場成長にさらに貢献すると期待されています。例えば、2022年11月、Neurosteer社は、単一チャンネル脳波（EEG）脳モニタリングプラットフォームのFDA承認を確保しました。同社は、接着剤で裏打ちされた電極ストリップを組み込むことで従来のEEGシステムを革新的に改善し、コンパクトなセンサーにシームレスにリンクすることで、より簡素化されたユーザーフレンドリーなソリューションを提供しています。

脳イメージングデバイスレポート・ハイライト

• 製品別では、デバイス部門が売上シェアの80％以上を占め、市場を独占しています。
• アクセサリー分野は、2024年から2030年にかけて最も速いCAGR 9.05％で成長すると予測されています。
• 用途別では、脳腫瘍分野が2023年に約23％の最大市場シェアを占めました。
• てんかんセグメントは、予測期間中にCAGR 9.29%の最速成長が見込まれています。
• モダリティ別では、固定式脳イメージングデバイスセグメントが2023年に収益シェアの47.15％を獲得して市場を独占しました。
• ポータブル脳イメージングデバイスセグメントは、2024年から2030年にかけて最も速いCAGR 8.90％で成長すると予測されています。
• 最終用途別では、病院が2023年に37.73％と大半の収益シェアを占めました。
• 北米は2023年に39％以上のシェアで市場を独占しました。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 脳イメージングデバイス市場の変数、動向、範囲

• 市場系統の見通し
  • 親市場の見通し
  • 関連/付随市場の見通し
• 市場力学
  • 市場牽引要因分析
  • 市場抑制要因分析
• 脳イメージングデバイス市場分析ツール
  • 業界分析- ポーターのファイブフォース分析
  • PESTEL分析

第4章 脳イメージングデバイス市場：製品の推定・動向分析

• セグメントダッシュボード
• 世界の脳イメージングデバイス市場：製品の変動分析
• 世界の脳イメージングデバイス市場規模と動向分析、製品別、2018～2030年
• デバイス
• アクセサリー

第5章 脳イメージングデバイス市場：用途の推定・動向分析

• セグメントダッシュボード
• 世界の脳イメージングデバイス市場：用途の変動分析
• 世界の脳イメージングデバイス市場規模と動向分析、用途別、2018～2030年
• 脳卒中
• 脳腫瘍
• 外傷性脳損傷（TBI）
• てんかん
• 睡眠時無呼吸
• 頭痛
• 構造異常
• その他の用途

第6章 脳イメージングデバイス市場：モダリティの推定・動向分析

• セグメントダッシュボード
• 世界の脳イメージングデバイス市場：モダリティの変動分析
• 世界の脳イメージングデバイス市場規模と動向分析、モダリティ別、2018～2030年
• 固定
• ポータブル
• ウェアラブル

第7章 脳イメージングデバイス市場：最終用途の推定・動向分析

• セグメントダッシュボード
• 世界の脳イメージングデバイス市場：最終用途変動分析
• 世界の脳イメージングデバイス市場規模と動向分析、最終用途別、2018～2030年
• 病院
• 画像診断センター
• 外来手術センター
• その他

第8章 脳イメージングデバイス市場：製品、用途、モダリティ、最終用途別の地域推定・動向分析

• 地域別市場シェア分析、2023年および2030年
• 地域市場ダッシュボード
• 世界地域市場スナップショット
• 市場規模、予測動向分析、2018年から2030年
• 北米
• 欧州
• アジア太平洋地域
• ラテンアメリカ
• 中東・アフリカ

第9章 競合情勢

• 主要市場参入企業による最近の動向と影響分析
• 企業/競合の分類
• 主要企業の市場シェア分析、2023年
• 企業ポジション分析
• 企業分類（新興企業、イノベーター、リーダー）
• 企業プロファイル
  • GE HealthCare
  • Siemens Healthineers AG
  • Koninklijke Philips NV
  • Medtronic
  • Compumedics Limited
  • MEGIN
  • CTF MEG Neuro Innovations, Inc
  • FieldLine Inc
  • Cerca Magnetics Limited
  • Advanced Brain Monitoring, Inc.
  • Canon Medical Systems Corporation
  • Natus
  • Magstim EGI
  • Cadwell
  • Nihon Kohden Corporation
  • NeuroLogica Corp.

List of Tables

• Table 1. List of secondary sources
• Table 2. List of abbreviation
• Table 3. North America brain imaging devices market, By country, 2018 - 2030 (USD Million)
• Table 4. North America brain imaging devices market, By product, 2018 - 2030 (USD Million)
• Table 5. North America brain imaging devices market, By application, 2018 - 2030 (USD Million)
• Table 6. North America brain imaging devices market, By modality, 2018 - 2030 (USD Million)
• Table 7. North America brain imaging devices market, By end-use, 2018 - 2030 (USD Million)
• Table 8. U.S. brain imaging devices market, By product, 2018 - 2030 (USD Million)
• Table 9. U.S. brain imaging devices market, By application, 2018 - 2030 (USD Million)
• Table 10. U.S. brain imaging devices market, By modality, 2018 - 2030 (USD Million)
• Table 11. U.S. brain imaging devices market, By end-use, 2018 - 2030 (USD Million)
• Table 12. Canada brain imaging devices market, By product, 2018 - 2030 (USD Million)
• Table 13. Canada brain imaging devices market, By application, 2018 - 2030 (USD Million)
• Table 14. Canada brain imaging devices market, By modality, 2018 - 2030 (USD Million)
• Table 15. Canada brain imaging devices market, By end-use, 2018 - 2030 (USD Million)
• Table 16. Mexico brain imaging devices market, By product, 2018 - 2030 (USD Million)
• Table 17. Mexico brain imaging devices market, By application, 2018 - 2030 (USD Million)
• Table 18. Mexico brain imaging devices market, By modality, 2018 - 2030 (USD Million)
• Table 19. Mexico brain imaging devices market, By end-use, 2018 - 2030 (USD Million)
• Table 20. Europe brain imaging devices market, By country, 2018 - 2030 (USD Million)
• Table 21. Europe brain imaging devices market, By product, 2018 - 2030 (USD Million)
• Table 22. Europe brain imaging devices market, By application, 2018 - 2030 (USD Million)
• Table 23. Europe brain imaging devices market, By modality, 2018 - 2030 (USD Million)
• Table 24. Europe brain imaging devices market, By end-use, 2018 - 2030 (USD Million)
• Table 25. UK brain imaging devices market, By product, 2018 - 2030 (USD Million)
• Table 26. UK brain imaging devices market, By application, 2018 - 2030 (USD Million)
• Table 27. UK brain imaging devices market, By modality, 2018 - 2030 (USD Million)
• Table 28. UK brain imaging devices market, By end-use, 2018 - 2030 (USD Million)
• Table 29. Germany brain imaging devices market, By product, 2018 - 2030 (USD Million)
• Table 30. Germany brain imaging devices market, By application, 2018 - 2030 (USD Million)
• Table 31. Germany brain imaging devices market, By modality, 2018 - 2030 (USD Million)
• Table 32. Germany brain imaging devices market, By end-use, 2018 - 2030 (USD Million)
• Table 33. France brain imaging devices market, By product, 2018 - 2030 (USD Million)
• Table 34. France brain imaging devices market, By application, 2018 - 2030 (USD Million)
• Table 35. France brain imaging devices market, By modality, 2018 - 2030 (USD Million)
• Table 36. France brain imaging devices market, By end-use, 2018 - 2030 (USD Million)
• Table 37. Italy brain imaging devices market, By product, 2018 - 2030 (USD Million)
• Table 38. Italy brain imaging devices market, By application, 2018 - 2030 (USD Million)
• Table 39. Italy brain imaging devices market, By modality, 2018 - 2030 (USD Million)
• Table 40. Italy brain imaging devices market, By end-use, 2018 - 2030 (USD Million)
• Table 41. Denmark brain imaging devices market, By product, 2018 - 2030 (USD Million)
• Table 42. Denmark brain imaging devices market, By application, 2018 - 2030 (USD Million)
• Table 43. Denmark brain imaging devices market, By modality, 2018 - 2030 (USD Million)
• Table 44. Denmark brain imaging devices market, By end-use, 2018 - 2030 (USD Million)
• Table 45. Sweden brain imaging devices market, By product, 2018 - 2030 (USD Million)
• Table 46. Sweden brain imaging devices market, By application, 2018 - 2030 (USD Million)
• Table 47. Sweden brain imaging devices market, By modality, 2018 - 2030 (USD Million)
• Table 48. Sweden brain imaging devices market, By end-use, 2018 - 2030 (USD Million)
• Table 49. Norway brain imaging devices market, By product, 2018 - 2030 (USD Million)
• Table 50. Norway brain imaging devices market, By application, 2018 - 2030 (USD Million)
• Table 51. Norway brain imaging devices market, By modality, 2018 - 2030 (USD Million)
• Table 52. Norway brain imaging devices market, By end-use, 2018 - 2030 (USD Million)
• Table 53. Asia Pacific brain imaging devices market, By country, 2018 - 2030 (USD Million)
• Table 54. Asia Pacific brain imaging devices market, By product, 2018 - 2030 (USD Million)
• Table 55. Asia Pacific brain imaging devices market, By application, 2018 - 2030 (USD Million)
• Table 56. Asia Pacific brain imaging devices market, By modality, 2018 - 2030 (USD Million)
• Table 57. Asia Pacific brain imaging devices market, By end-use, 2018 - 2030 (USD Million)
• Table 58. Japan brain imaging devices market, By product, 2018 - 2030 (USD Million)
• Table 59. Japan brain imaging devices market, By application, 2018 - 2030 (USD Million)
• Table 60. Japan brain imaging devices market, By modality, 2018 - 2030 (USD Million)
• Table 61. Japan brain imaging devices market, By end-use, 2018 - 2030 (USD Million)
• Table 62. China brain imaging devices market, By product, 2018 - 2030 (USD Million)
• Table 63. China brain imaging devices market, By application, 2018 - 2030 (USD Million)
• Table 64. China brain imaging devices market, By modality, 2018 - 2030 (USD Million)
• Table 65. China brain imaging devices market, By end-use, 2018 - 2030 (USD Million)
• Table 66. India brain imaging devices market, By product, 2018 - 2030 (USD Million)
• Table 67. India brain imaging devices market, By application, 2018 - 2030 (USD Million)
• Table 68. India brain imaging devices market, By modality, 2018 - 2030 (USD Million)
• Table 69. India brain imaging devices market, By end-use, 2018 - 2030 (USD Million)
• Table 70. Australia brain imaging devices market, By product, 2018 - 2030 (USD Million)
• Table 71. Australia brain imaging devices market, By application, 2018 - 2030 (USD Million)
• Table 72. Australia brain imaging devices market, By modality, 2018 - 2030 (USD Million)
• Table 73. Australia brain imaging devices market, By end-use, 2018 - 2030 (USD Million)
• Table 74. South Korea brain imaging devices market, By product, 2018 - 2030 (USD Million)
• Table 75. South Korea brain imaging devices market, By application, 2018 - 2030 (USD Million)
• Table 76. South Korea brain imaging devices market, By modality, 2018 - 2030 (USD Million)
• Table 77. South Korea brain imaging devices market, By end-use, 2018 - 2030 (USD Million)
• Table 78. Thailand brain imaging devices market, By product, 2018 - 2030 (USD Million)
• Table 79. Thailand brain imaging devices market, By application, 2018 - 2030 (USD Million)
• Table 80. Thailand brain imaging devices market, By modality, 2018 - 2030 (USD Million)
• Table 81. Thailand brain imaging devices market, By end-use, 2018 - 2030 (USD Million)
• Table 82. Latin America brain imaging devices market, By Country, 2018 - 2030 (USD Million)
• Table 83. Latin America brain imaging devices market, By product, 2018 - 2030 (USD Million)
• Table 84. Latin America brain imaging devices market, By application, 2018 - 2030 (USD Million)
• Table 85. Latin America brain imaging devices market, By modality, 2018 - 2030 (USD Million)
• Table 86. Latin America brain imaging devices market, By end-use, 2018 - 2030 (USD Million)
• Table 87. Brazil brain imaging devices market, By product, 2018 - 2030 (USD Million)
• Table 88. Brazil brain imaging devices market, By application, 2018 - 2030 (USD Million)
• Table 89. Brazil brain imaging devices market, By modality, 2018 - 2030 (USD Million)
• Table 90. Brazil brain imaging devices market, By end-use, 2018 - 2030 (USD Million)
• Table 91. Argentina brain imaging devices market, By product, 2018 - 2030 (USD Million)
• Table 92. Argentina brain imaging devices market, By application, 2018 - 2030 (USD Million)
• Table 93. Argentina brain imaging devices market, By modality, 2018 - 2030 (USD Million)
• Table 94. Argentina brain imaging devices market, By end-use, 2018 - 2030 (USD Million)
• Table 95. Middle East & Africa brain imaging devices market, By country, 2018 - 2030 (USD Million)
• Table 96. Middle East & Africa brain imaging devices market, By product, 2018 - 2030 (USD Million)
• Table 97. Middle East & Africa brain imaging devices market, By application, 2018 - 2030 (USD Million)
• Table 98. Middle East & Africa brain imaging devices market, By modality, 2018 - 2030 (USD Million)
• Table 99. Middle East & Africa brain imaging devices market, By end-use, 2018 - 2030 (USD Million)
• Table 100. South Africa brain imaging devices market, By product, 2018 - 2030 (USD Million)
• Table 101. South Africa brain imaging devices market, By application, 2018 - 2030 (USD Million)
• Table 102. South Africa brain imaging devices market, By modality, 2018 - 2030 (USD Million)
• Table 103. South Africa brain imaging devices market, By end-use, 2018 - 2030 (USD Million)
• Table 104. Saudi Arabia brain imaging devices market, By product, 2018 - 2030 (USD Million)
• Table 105. Saudi Arabia brain imaging devices market, By application, 2018 - 2030 (USD Million)
• Table 106. Saudi Arabia brain imaging devices market, By modality, 2018 - 2030 (USD Million)
• Table 107. Saudi Arabia brain imaging devices market, By end-use, 2018 - 2030 (USD Million)
• Table 108. UAE brain imaging devices market, By product, 2018 - 2030 (USD Million)
• Table 109. UAE brain imaging devices market, By application, 2018 - 2030 (USD Million)
• Table 110. UAE brain imaging devices market, By modality, 2018 - 2030 (USD Million)
• Table 111. UAE brain imaging devices market, By end-use, 2018 - 2030 (USD Million)
• Table 112. Kuwait brain imaging devices market, By product, 2018 - 2030 (USD Million)
• Table 113. Kuwait brain imaging devices market, By application, 2018 - 2030 (USD Million)
• Table 114. Kuwait brain imaging devices market, By modality, 2018 - 2030 (USD Million)
• Table 115. Kuwait brain imaging devices market, By end-use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Data triangulation techniques
• Fig. 3 Primary research pattern
• Fig. 4 Primary interviews in North America
• Fig. 5 Primary interviews in Europe
• Fig. 6 Primary interviews in APAC
• Fig. 7 Primary interviews in Latin America
• Fig. 8 Primary interviews in MEA
• Fig. 9 Market research approaches
• Fig. 10 Value-chain-based sizing & forecasting
• Fig. 11 QFD modeling for market share assessment
• Fig. 12 Market formulation & validation
• Fig. 13 Brain imaging devices market: market outlook
• Fig. 14 Parent market outlook
• Fig. 15 Related/ancillary market outlook
• Fig. 16 Penetration and growth prospect mapping
• Fig. 17 Industry value chain analysis
• Fig. 18 Brain imaging devices market driver impact
• Fig. 19 Brain imaging devices market restraint impact
• Fig. 20 Brain imaging devices market: Product movement analysis
• Fig. 21 Brain imaging devices market: Product outlook and key takeaways
• Fig. 22 Devices market estimates and forecast, 2018 - 2030
• Fig. 23 EEG market estimates and forecast, 2018 - 2030
• Fig. 24 MEG market estimates and forecast, 2018 - 2030
• Fig. 25 MRI market estimates and forecast, 2018 - 2030
• Fig. 26 CT market estimates and forecast, 2018 - 2030
• Fig. 27 PET market estimates and forecast, 2018 - 2030
• Fig. 28 Other devices market estimates and forecast, 2018 - 2030
• Fig. 29 Accessories market estimates and forecast, 2018 - 2030
• Fig. 30 Electrodes market estimates and forecast, 2018 - 2030
• Fig. 31 Sensors market estimates and forecast, 2018 - 2030
• Fig. 32 Other accessories market estimates and forecast, 2018 - 2030
• Fig. 33 Brain imaging devices market: Application movement analysis
• Fig. 34 Brain imaging devices market: Application outlook and key takeaways
• Fig. 35 Stroke market estimates and forecast, 2018 - 2030
• Fig. 36 Brain tumor market estimates and forecast, 2018 - 2030
• Fig. 37 Traumatic brain injury (TBI) market estimates and forecast, 2018 - 2030
• Fig. 38 Epilepsy market estimates and forecast, 2018 - 2030
• Fig. 39 Sleep apnea market estimates and forecast, 2018 - 2030
• Fig. 40 Headache market estimates and forecast, 2018 - 2030
• Fig. 41 Structural anomalies market estimates and forecast, 2018 - 2030
• Fig. 42 Other applications market estimates and forecast, 2018 - 2030
• Fig. 43 Brain imaging devices market: Modality movement analysis
• Fig. 44 Brain imaging devices market: Modality outlook and key takeaways
• Fig. 45 Fixed market estimates and forecast, 2018 - 2030
• Fig. 46 Portable market estimates and forecast, 2018 - 2030
• Fig. 47 Wearable market estimates and forecast, 2018 - 2030
• Fig. 48 Brain imaging devices market: End-use movement analysis
• Fig. 49 Brain imaging devices market: End-use outlook and key takeaways
• Fig. 50 Hospitals market estimates and forecast, 2018 - 2030
• Fig. 51 Diagnostic imaging centers market estimates and forecast, 2018 - 2030
• Fig. 52 Ambulatory surgery centers market estimates and forecast, 2018 - 2030
• Fig. 53 Others end users market estimates and forecast, 2018 - 2030
• Fig. 54 Global brain imaging devices market: Regional movement analysis
• Fig. 55 Global brain imaging devices market: Regional outlook and key takeaways
• Fig. 56 North America
• Fig. 57 North America market estimates and forecasts, 2018 - 2030
• Fig. 58 U.S.
• Fig. 59 U.S. market estimates and forecasts, 2018 - 2030
• Fig. 60 Canada
• Fig. 61 Canada market estimates and forecasts, 2018 - 2030
• Fig. 62 Mexico
• Fig. 63 Mexico market estimates and forecasts, 2018 - 2030
• Fig. 64 Europe
• Fig. 65 Europe market estimates and forecasts, 2018 - 2030
• Fig. 66 UK
• Fig. 67 UK market estimates and forecasts, 2018 - 2030
• Fig. 68 Germany
• Fig. 69 Germany market estimates and forecasts, 2018 - 2030
• Fig. 70 France
• Fig. 71 France market estimates and forecasts, 2018 - 2030
• Fig. 72 Italy
• Fig. 73 Italy market estimates and forecasts, 2018 - 2030
• Fig. 74 Spain
• Fig. 75 Spain market estimates and forecasts, 2018 - 2030
• Fig. 76 Denmark
• Fig. 77 Denmark market estimates and forecasts, 2018 - 2030
• Fig. 78 Sweden
• Fig. 79 Sweden market estimates and forecasts, 2018 - 2030
• Fig. 80 Norway
• Fig. 81 Norway market estimates and forecasts, 2018 - 2030
• Fig. 82 Asia Pacific
• Fig. 83 Asia Pacific market estimates and forecasts, 2018 - 2030
• Fig. 84 China
• Fig. 85 China market estimates and forecasts, 2018 - 2030
• Fig. 86 Japan
• Fig. 87 Japan market estimates and forecasts, 2018 - 2030
• Fig. 88 India
• Fig. 89 India market estimates and forecasts, 2018 - 2030
• Fig. 90 Thailand
• Fig. 91 Thailand market estimates and forecasts, 2018 - 2030
• Fig. 92 South Korea
• Fig. 93 South Korea market estimates and forecasts, 2018 - 2030
• Fig. 94 Australia
• Fig. 95 Australia market estimates and forecasts, 2018 - 2030
• Fig. 96 Latin America
• Fig. 97 Latin America market estimates and forecasts, 2018 - 2030
• Fig. 98 Brazil
• Fig. 99 Brazil market estimates and forecasts, 2018 - 2030
• Fig. 100 Mexico
• Fig. 101 Mexico market estimates and forecasts, 2018 - 2030
• Fig. 102 Argentina
• Fig. 103 Argentina market estimates and forecasts, 2018 - 2030
• Fig. 104 Middle East and Africa
• Fig. 105 Middle East and Africa market estimates and forecasts, 2018 - 2030
• Fig. 106 South Africa
• Fig. 107 South Africa market estimates and forecasts, 2018 - 2030
• Fig. 108 Saudi Arabia
• Fig. 109 Saudi Arabia market estimates and forecasts, 2018 - 2030
• Fig. 110 UAE
• Fig. 111 UAE market estimates and forecasts, 2018 - 2030
• Fig. 112 Kuwait
• Fig. 113 Kuwait market estimates and forecasts, 2018 - 2030
• Fig. 114 Market share of key market players - Brain imaging devices market

Brain Imaging Devices Market Growth & Trends:

The global brain imaging devices market size is anticipated to reach USD 9.04 billion by 2030, growing at a CAGR of 8.14% from 2024 to 2030. Key drivers propelling market growth include technological advancements, increasing R&D activities, and the growing prevalence of brain or neurological disorders. For instance, the International Agency for Research on Cancer reported approximately 321,731 cases of brain and central nervous system cancer worldwide in 2022. This type of cancer was noted to rank 19th among all other types of cancer.

Technological advancements are expected to be one of the primary factors contributing to market growth. These advancements encompass a spectrum of innovations, including enhanced imaging resolution, improved data processing capabilities, and the development of novel imaging modalities. Such progress not only enhances the accuracy and efficiency of brain imaging but also expands its applications across various fields such as neuroscience, neurology, psychiatry, and neurosurgery. For instance, in February 2024, Philips partnered with Synthetic MR, a company specializing in magnetic resonance imaging (MRI) software solutions, to introduce Smart Quant Neuro 3D, marking a notable advancement in providing objective decision support for the diagnosis and assessment of therapy effectiveness in brain disorders like multiple sclerosis (MS), traumatic brain injury (TBI), and dementia. The Smart Quant Neuro 3D technology provides automated measurements of various brain tissues, aids in decision-making for brain diseases,

monitors disease progression, and assesses therapy results.

Additionally, the rising prevalence of neurological disorders and an aging population contribute to the increasing demand for advanced brain imaging technologies. With continuous research and development efforts driving innovation and the expansion of the market. Furthermore, various initiatives undertaken by market players are further expected to contribute to market growth. For instance, in November 2022, Neurosteer secured FDA approval for its single-channel electroencephalogram (EEG) brain monitoring platform. The company innovatively improved the conventional EEG system by incorporating an adhesive-backed electrode strip, seamlessly linking to a compact sensor, thus offering a more simplified and user-friendly solution.

Brain Imaging Devices Report Highlights:

• Based on product, the devices segment dominated the market by capturing over 80% of the revenue share
• The accessories segment is anticipated to grow at the fastest CAGR of 9.05% from 2024 to 2030
• Based on application, the brain tumor segment held the largest market share of around 23% in 2023
• The epilepsy segment is expected to grow at the fastest CAGR of 9.29% during the forecast period
• Based on modality, the fixed brain imaging devices segment dominated the market in 2023 by capturing 47.15% of the revenue share
• Portable brain imaging devices segment is expected to grow at the fastest CAGR of 8.90% from 2024 to 2030
• Based on end-use, hospitals held a majority revenue share of 37.73% in 2023
• North America dominated the market with a share of over 39% in 2023

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. Application
  • 1.2.3. Modality
  • 1.2.4. End-use
  • 1.2.5. Regional scope
  • 1.2.6. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
    • 1.4.5.1. Data for primary interviews in North America
    • 1.4.5.2. Data for primary interviews in Europe
    • 1.4.5.3. Data for primary interviews in Asia Pacific
    • 1.4.5.4. Data for primary interviews in Latin America
    • 1.4.5.5. Data for Primary interviews in MEA
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product outlook
  • 2.2.2. Application outlook
  • 2.2.3. Modality outlook
  • 2.2.4. End-use outlook
  • 2.2.5. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Brain Imaging Devices Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Growing incidence of neurological disorders
    • 3.2.1.2. Technological advancements
    • 3.2.1.3. Increase in R&D activities
    • 3.2.1.4. Rising awareness of early disease diagnosis and treatment
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. High cost of brain imaging devices
    • 3.2.2.2. Lack of skilled professionals to operate the technologically advanced brain imaging devices
    • 3.2.2.3. Stringent regulatory approvals
• 3.3. Brain Imaging Devices Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape

Chapter 4. Brain Imaging Devices Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Global Brain Imaging Devices Product Market Movement Analysis
• 4.3. Global Brain Imaging Devices Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
• 4.4. Devices
  • 4.4.1. Devices market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.2. EEG
    • 4.4.2.1. EEG market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.3. MEG
    • 4.4.3.1. MEG market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.4. MRI
    • 4.4.4.1. MRI market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.5. CT
    • 4.4.5.1. CT market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.6. PET
    • 4.4.6.1. PET market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.7. Other Devices
    • 4.4.7.1. Other devices market estimates and forecasts 2018 to 2030 (USD Million)
• 4.5. Accessories
  • 4.5.1. Accessories market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5.2. Electrodes
    • 4.5.2.1. Electrodes market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5.3. Sensors
    • 4.5.3.1. Sensors market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5.4. Other Accessories
    • 4.5.4.1. Other accessories market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Brain Imaging Devices Market: Application Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Global Brain Imaging Devices Application Market Movement Analysis
• 5.3. Global Brain Imaging Devices Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
• 5.4. Stroke
  • 5.4.1. Stroke market estimates and forecasts 2018 to 2030 (USD Million)
• 5.5. Brain Tumor
  • 5.5.1. Brain tumor market estimates and forecasts 2018 to 2030 (USD Million)
• 5.6. Traumatic brain injury (TBI)
  • 5.6.1. Traumatic brain injury (TBI) market estimates and forecasts 2018 to 2030 (USD Million)
• 5.7. Epilepsy
  • 5.7.1. Epilepsy market estimates and forecasts 2018 to 2030 (USD Million)
• 5.8. Sleep Apnea
  • 5.8.1. Sleep apnea market estimates and forecasts 2018 to 2030 (USD Million)
• 5.9. Headache
  • 5.9.1. Headache market estimates and forecasts 2018 to 2030 (USD Million)
• 5.10. Structural anomalies
  • 5.10.1. Structural anomalies market estimates and forecasts 2018 to 2030 (USD Million)
• 5.11. Other Applications
  • 5.11.1. Other applications market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Brain Imaging Devices Market: Modality Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Global Brain Imaging Devices Modality Market Movement Analysis
• 6.3. Global Brain Imaging Devices Market Size & Trend Analysis, by Modality, 2018 to 2030 (USD Million)
• 6.4. Fixed
  • 6.4.1. Fixed market estimates and forecasts 2018 to 2030 (USD Million)
• 6.5. Portable
  • 6.5.1. Portable market estimates and forecasts 2018 to 2030 (USD Million)
• 6.6. Wearable
  • 6.6.1. Wearable market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Brain Imaging Devices Market: End Use Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Global Brain Imaging Devices End Use Market Movement Analysis
• 7.3. Global Brain Imaging Devices Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
• 7.4. Hospitals
  • 7.4.1. Hospitals market estimates and forecasts 2018 to 2030 (USD Million)
• 7.5. Diagnostic Imaging Centers
  • 7.5.1. Diagnostic imaging centers market estimates and forecasts 2018 to 2030 (USD Million)
• 7.6. Ambulatory Surgery Centers
  • 7.6.1. Ambulatory surgery centers market estimates and forecasts 2018 to 2030 (USD Million)
• 7.7. Others
  • 7.7.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Brain Imaging Devices Market: Regional Estimates & Trend Analysis By Product , Application, Modality, End-use

• 8.1. Regional Market Share Analysis, 2023 & 2030
• 8.2. Regional Market Dashboard
• 8.3. Global Regional Market Snapshot
• 8.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 8.5. North America
  • 8.5.1. U.S.
    • 8.5.1.1. Key country dynamics
    • 8.5.1.2. Competitive scenario
    • 8.5.1.3. Regulatory framework
    • 8.5.1.4. Reimbursement structure
    • 8.5.1.5. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.2. Canada
    • 8.5.2.1. Key country dynamics
    • 8.5.2.2. Competitive scenario
    • 8.5.2.3. Regulatory framework
    • 8.5.2.4. Reimbursement structure
    • 8.5.2.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.3. Mexico
    • 8.5.3.1. Key country dynamics
    • 8.5.3.2. Competitive scenario
    • 8.5.3.3. Regulatory framework
    • 8.5.3.4. Reimbursement structure
    • 8.5.3.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
• 8.6. Europe
  • 8.6.1. UK
    • 8.6.1.1. Key country dynamics
    • 8.6.1.2. Competitive scenario
    • 8.6.1.3. Regulatory framework
    • 8.6.1.4. Reimbursement structure
    • 8.6.1.5. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.2. Germany
    • 8.6.2.1. Key country dynamics
    • 8.6.2.2. Competitive scenario
    • 8.6.2.3. Regulatory framework
    • 8.6.2.4. Reimbursement structure
    • 8.6.2.5. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.3. France
    • 8.6.3.1. Key country dynamics
    • 8.6.3.2. Competitive scenario
    • 8.6.3.3. Regulatory framework
    • 8.6.3.4. Reimbursement structure
    • 8.6.3.5. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.4. Italy
    • 8.6.4.1. Key country dynamics
    • 8.6.4.2. Competitive scenario
    • 8.6.4.3. Regulatory framework
    • 8.6.4.4. Reimbursement structure
    • 8.6.4.5. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.5. Spain
    • 8.6.5.1. Key country dynamics
    • 8.6.5.2. Competitive scenario
    • 8.6.5.3. Regulatory framework
    • 8.6.5.4. Reimbursement structure
    • 8.6.5.5. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.6. Norway
    • 8.6.6.1. Key country dynamics
    • 8.6.6.2. Competitive scenario
    • 8.6.6.3. Regulatory framework
    • 8.6.6.4. Reimbursement structure
    • 8.6.6.5. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.7. Sweden
    • 8.6.7.1. Key country dynamics
    • 8.6.7.2. Competitive scenario
    • 8.6.7.3. Regulatory framework
    • 8.6.7.4. Reimbursement structure
    • 8.6.7.5. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.8. Denmark
    • 8.6.8.1. Key country dynamics
    • 8.6.8.2. Competitive scenario
    • 8.6.8.3. Regulatory framework
    • 8.6.8.4. Reimbursement structure
    • 8.6.8.5. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
• 8.7. Asia Pacific
  • 8.7.1. Japan
    • 8.7.1.1. Key country dynamics
    • 8.7.1.2. Competitive scenario
    • 8.7.1.3. Regulatory framework
    • 8.7.1.4. Reimbursement structure
    • 8.7.1.5. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.2. China
    • 8.7.2.1. Key country dynamics
    • 8.7.2.2. Competitive scenario
    • 8.7.2.3. Regulatory framework
    • 8.7.2.4. Reimbursement structure
    • 8.7.2.5. China market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.3. India
    • 8.7.3.1. Key country dynamics
    • 8.7.3.2. Competitive scenario
    • 8.7.3.3. Regulatory framework
    • 8.7.3.4. Reimbursement structure
    • 8.7.3.5. India market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.4. Australia
    • 8.7.4.1. Key country dynamics
    • 8.7.4.2. Competitive scenario
    • 8.7.4.3. Regulatory framework
    • 8.7.4.4. Reimbursement structure
    • 8.7.4.5. Australia market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.5. South Korea
    • 8.7.5.1. Key country dynamics
    • 8.7.5.2. Competitive scenario
    • 8.7.5.3. Regulatory framework
    • 8.7.5.4. Reimbursement structure
    • 8.7.5.5. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.6. Thailand
    • 8.7.6.1. Key country dynamics
    • 8.7.6.2. Competitive scenario
    • 8.7.6.3. Regulatory framework
    • 8.7.6.4. Reimbursement structure
    • 8.7.6.5. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
• 8.8. Latin America
  • 8.8.1. Brazil
    • 8.8.1.1. Key country dynamics
    • 8.8.1.2. Competitive scenario
    • 8.8.1.3. Regulatory framework
    • 8.8.1.4. Reimbursement structure
    • 8.8.1.5. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.8.2. Argentina
    • 8.8.2.1. Key country dynamics
    • 8.8.2.2. Competitive scenario
    • 8.8.2.3. Regulatory framework
    • 8.8.2.4. Reimbursement structure
    • 8.8.2.5. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
• 8.9. MEA
  • 8.9.1. South Africa
    • 8.9.1.1. Key country dynamics
    • 8.9.1.2. Competitive scenario
    • 8.9.1.3. Regulatory framework
    • 8.9.1.4. Reimbursement structure
    • 8.9.1.5. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.9.2. Saudi Arabia
    • 8.9.2.1. Key country dynamics
    • 8.9.2.2. Competitive scenario
    • 8.9.2.3. Regulatory framework
    • 8.9.2.4. Reimbursement structure
    • 8.9.2.5. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.9.3. UAE
    • 8.9.3.1. Key country dynamics
    • 8.9.3.2. Competitive scenario
    • 8.9.3.3. Regulatory framework
    • 8.9.3.4. Reimbursement structure
    • 8.9.3.5. UAE market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.9.4. Kuwait
    • 8.9.4.1. Key country dynamics
    • 8.9.4.2. Competitive scenario
    • 8.9.4.3. Regulatory framework
    • 8.9.4.4. Reimbursement structure
    • 8.9.4.5. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Recent Developments & Impact Analysis, By Key Market Participants
• 9.2. Company/Competition Categorization
• 9.3. Key company market share analysis, 2023
• 9.4. Company Position Analysis
• 9.5. Company Categorization (Emerging Players, Innovators and Leaders
• 9.6. Company Profiles
  • 9.6.1. GE HealthCare
    • 9.6.1.1. Company overview
    • 9.6.1.2. Financial performance
    • 9.6.1.3. Product benchmarking
    • 9.6.1.4. Strategic initiatives
  • 9.6.2. Siemens Healthineers AG
    • 9.6.2.1. Company overview
    • 9.6.2.2. Financial performance
    • 9.6.2.3. Product benchmarking
    • 9.6.2.4. Strategic initiatives
  • 9.6.3. Koninklijke Philips N.V.
    • 9.6.3.1. Company overview
    • 9.6.3.2. Financial performance
    • 9.6.3.3. Product benchmarking
    • 9.6.3.4. Strategic initiatives
  • 9.6.4. Medtronic
    • 9.6.4.1. Company overview
    • 9.6.4.2. Financial performance
    • 9.6.4.3. Product benchmarking
    • 9.6.4.4. Strategic initiatives
  • 9.6.5. Compumedics Limited
    • 9.6.5.1. Company overview
    • 9.6.5.2. Financial performance
    • 9.6.5.3. Product benchmarking
    • 9.6.5.4. Strategic initiatives
  • 9.6.6. MEGIN
    • 9.6.6.1. Company overview
    • 9.6.6.2. Financial performance
    • 9.6.6.3. Product benchmarking
    • 9.6.6.4. Strategic initiatives
  • 9.6.7. CTF MEG Neuro Innovations, Inc
    • 9.6.7.1. Company overview
    • 9.6.7.2. Financial performance
    • 9.6.7.3. Product benchmarking
    • 9.6.7.4. Strategic initiatives
  • 9.6.8. FieldLine Inc
    • 9.6.8.1. Company overview
    • 9.6.8.2. Financial performance
    • 9.6.8.3. Product benchmarking
    • 9.6.8.4. Strategic initiatives
  • 9.6.9. Cerca Magnetics Limited
    • 9.6.9.1. Company overview
    • 9.6.9.2. Financial performance
    • 9.6.9.3. Product benchmarking
    • 9.6.9.4. Strategic initiatives
  • 9.6.10. Advanced Brain Monitoring, Inc.
    • 9.6.10.1. Company overview
    • 9.6.10.2. Financial performance
    • 9.6.10.3. Product benchmarking
    • 9.6.10.4. Strategic initiatives
  • 9.6.11. Canon Medical Systems Corporation
    • 9.6.11.1. Company overview
    • 9.6.11.2. Financial performance
    • 9.6.11.3. Product benchmarking
    • 9.6.11.4. Strategic initiatives
  • 9.6.12. Natus
    • 9.6.12.1. Company overview
    • 9.6.12.2. Financial performance
    • 9.6.12.3. Product benchmarking
    • 9.6.12.4. Strategic initiatives
  • 9.6.13. Magstim EGI
    • 9.6.13.1. Company overview
    • 9.6.13.2. Financial performance
    • 9.6.13.3. Product benchmarking
    • 9.6.13.4. Strategic initiatives
  • 9.6.14. Cadwell
    • 9.6.14.1. Company overview
    • 9.6.14.2. Financial performance
    • 9.6.14.3. Product benchmarking
    • 9.6.14.4. Strategic initiatives
  • 9.6.15. Nihon Kohden Corporation
    • 9.6.15.1. Company overview
    • 9.6.15.2. Financial performance
    • 9.6.15.3. Product benchmarking
    • 9.6.15.4. Strategic initiatives
  • 9.6.16. NeuroLogica Corp.
    • 9.6.16.1. Company overview
    • 9.6.16.2. Financial performance
    • 9.6.16.3. Product benchmarking
    • 9.6.16.4. Strategic initiatives